Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (241-250 of 290) with videos related to

Pageof 29
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsJ Stuart Elborn, David E Geller, Douglas Conrad, et al.
Journal of Clinical Microbiology|June 8, 2018
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisPeter H Gilligan, Damian G Downey, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 8, 2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patientsPatrick A Flume, Donald R VanDevanter, Elizabeth E Morgan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 15, 2010
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)Yasunori Maeda, J Stuart Elborn, Michael D Parkins, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in BronchiectasisJames D Chalmers, Kelly L Moffitt, Guillermo Suarez-Cuartin, et al.
Frontiers in Cellular and Infection Microbiology|April 4, 2022
Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor LungsGisli G Einarsson, Bart M Vanaudenaerde, Christopher D Spence, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 9, 2019
Influence of azithromycin and allograft rejection on the post-lung transplant microbiotaChristopher D Spence, Bart Vanaudenaerde, Gísli G Einarsson, et al.
Thorax|March 15, 2015
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lungArlene M A Glasgow, Donna M Small, Aaron Scott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2019
Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosisLaura J Sherrard, Gisli G Einarsson, Elinor Johnston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2021
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftorGisli G Einarsson, Nicola J Ronan, Denver Mooney, et al.
Pageof 29

Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsJ Stuart Elborn, David E Geller, Douglas Conrad, et al.
Journal of Clinical Microbiology|June 8, 2018
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisPeter H Gilligan, Damian G Downey, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 8, 2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patientsPatrick A Flume, Donald R VanDevanter, Elizabeth E Morgan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 15, 2010
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)Yasunori Maeda, J Stuart Elborn, Michael D Parkins, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in BronchiectasisJames D Chalmers, Kelly L Moffitt, Guillermo Suarez-Cuartin, et al.
Frontiers in Cellular and Infection Microbiology|April 4, 2022
Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor LungsGisli G Einarsson, Bart M Vanaudenaerde, Christopher D Spence, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 9, 2019
Influence of azithromycin and allograft rejection on the post-lung transplant microbiotaChristopher D Spence, Bart Vanaudenaerde, Gísli G Einarsson, et al.
Thorax|March 15, 2015
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lungArlene M A Glasgow, Donna M Small, Aaron Scott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2019
Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosisLaura J Sherrard, Gisli G Einarsson, Elinor Johnston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2021
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftorGisli G Einarsson, Nicola J Ronan, Denver Mooney, et al.
Pageof 29